31/03/2017
Auris Medical Announces Receipt of Nasdaq Notice of Bid Price Deficiency
Auris Medical Holding AG(NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that onMarch 30, 2017, the Company received a letter from [...]
